Researchers have found that bowel cancer cells have a mechanism by which they can switch off some key molecules on their surfaces and thus escape being recognised and killed by the immunotherapy agents. Image: Colour-enhanced image of human colon cancer cells in culture. Credit: Annie Cavanagh. License: (CC BY 4.0) This may provide clues as […]Continue Reading ...
For the first time, scientists have created a scavenging molecule that provides long-lasting preventative protection against toxic nerve agents in rodents. Their therapy represents a major breakthrough in the field – as researchers have unsuccessfully spent 60 years in search of numerous effective approaches – and lays the groundwork for treatments that could shield at-risk […]Continue Reading ...
Researchers have developed designer molecules that may one day be able to seek out and trap deadly nerve agents and other toxic compounds in the environment – and possibly in humans. The scientists, led by organic chemists from The Ohio State University, call these new particles “molecular baskets.” As the name implies, these molecules are […]Continue Reading ...
July 19, 2018 Using an infrared sensor, biophysicists at Ruhr-Universität Bochum (RUB) have succeeded in analyzing quickly and easily which active agents affect the structure of proteins and how long that effect lasts. Thus, Prof Dr Klaus Gerwert and Dr Jörn Güldenhaupt performed time-resolved measurements of the changes to the structure of protein scaffolds, which […]Continue Reading ...
Scientists shed light on the neurological consequences of exposure to low-levels of nerve agents and suggest a drug that could treat some of the toxins’ effects.Continue Reading ...
The neurologic effects and treatment options for exposure to biologic and chemical agents are outlined in a newly published article by neurologists from the University of Colorado School of Medicine who collaborated on the article with military physicians. “We wrote this article to help neurohospitalists and other health care providers identify unusual neurologic illnesses that […]Continue Reading ...
Recently, a research team led by Maurizio Pellecchia at the University of California, Riverside, discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases. The team was successful in getting the drug to piggyback on 123B9, an agent they devised to target […]Continue Reading ...
April 26, 2018 Magnetic resonance imaging, or MRI, is a widely used medical tool for taking pictures of the insides of our body. One way to make MRI scans easier to read is through the use of contrast agents–magnetic dyes injected into the blood or given orally to patients that then travel to organs and […]Continue Reading ...
A evaluate of segment II trial knowledge from bapineuzumab and solanezumab reveals that “neither compound produced compelling proof of drug-like conduct that might justify their development into pivotal trials.” (Alzheimer’s & Dementia) “Addict agents” earn giant dollars for referring sufferers to remedy methods, however that every so often comes at a price. (STAT) Neurocrine’s valbenazine, […]Continue Reading ...
- New gene therapy cures babies with fatal ‘Bubble Boy’ disease
- No female mice? Scientists may still approve NIH grant
- What needs to be said about mental health in medicine
- Hickenlooper Expanded Medicaid, Created State-Run Marketplace To Insure Nearly All Coloradans
- Cancer cells grown in tumor-mimicking environment can help predict the effect of experimental drugs
- Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH
- Adhesive gel bonds to eye surface, could repair injuries without surgery
- The future of genomics: A podcast featuring Stanford geneticists
- As Syphilis Invades Rural America, A Fraying Health Safety Net Is Failing To Stop It
- APOE gene impacts sleep depending on gender and severity of Alzheimer’s
- PCORI’s newly approved awards focus on cancer pain and opioid use disorders
- New tool provides a standard way to measure effects of caring for survivors of TBI
- Smartphone use risks eye examination misdiagnosis
- How drug-resistant bugs grow in CF patients’ lungs
- Gordana Vunjak-Novakovic Elected to American Academy of Arts & Sciences
- Podcast: KHN’s ‘What The Health?’ You Have Questions, We Have Answers
- Diabetic drug shows potential to be repurposed as heart disease treatment for non-diabetic patients
- New estimation method assesses natural variations in sex ratio at birth
- UTA scientist receives $1.17 million grant for cancer research
- Coagulation factor VIIa prevents bleeds in hemophilia animal models